surmount-1 trial tirzepatide obesity without diabetes weight loss (ZEPBOUND) Approved for Chronic Management in Adults with ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or Tirzepatide lowers body weight for

References Eli Lilly

We serve patients from Frederick MD, Mt Pleasant MD, Braddock Heights MD, Walkersville MD, Lewistown MD, Urbana MD, Ballenger Creek MD, and surrounding areas

[2] [3] [4] Warn patients about the potential for somnolence, dizziness, confusion, difficulty concentrating, or visual effects, and advise patients against driving or operating machinery until they have gained sufficient experience on topiramate to gauge whether it adversely affects their mental performance, motor performance, and/or vision

However, they work differently

Tirzepatide is the new defining comparison in next-gen weight loss medications